GEBT Lot-to-Lot and Biological Variability

NCT04772261 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2022-01-18

No results posted yet for this study

Summary

The purpose of this study is to collect information regarding lot-to-lot variability in 13C-Spirulina test meal lets and within-subject biological variability.

Conditions

Interventions

DIAGNOSTIC_TEST

13C-Spirulina GEBT

Various lots of 13C-Spirulina GEBT test meals

Sponsors & Collaborators

  • Cairn Diagnostics

    lead INDUSTRY

Principal Investigators

  • Alex Ryder, MD, PhD · Cairn Diagnostics

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-05
Primary Completion
2022-01-10
Completion
2022-01-10
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04772261 on ClinicalTrials.gov